Pipeline Review for Kaposi Sarcoma: H1 2018 - Key Companies Involved & Therapeutic Landscape Analyzed - ResearchAndMarkets.com

DUBLIN--()--The "Kaposi Sarcoma - Pipeline Review, H1 2018" report has been added to ResearchAndMarkets.com's offering.

The pipeline guide provides a snapshot of the global therapeutic landscape of Kaposi Sarcoma (Infectious Disease).

The pipeline guide reviews pipeline therapeutics for Kaposi Sarcoma (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Kaposi Sarcoma (Infectious Disease) therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Kaposi Sarcoma (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

The pipeline guide reviews latest news related to pipeline therapeutics for Kaposi Sarcoma (Infectious Disease).

Companies Mentioned

  • Aphios Corp
  • Bristol-Myers Squibb Co
  • Cannabis Science Inc
  • Celgene Corp
  • Latitude Pharmaceuticals Inc
  • Merck & Co Inc
  • Ono Pharmaceutical Co Ltd
  • Tumorend Llc
  • VasGene Therapeutics Inc

Key Topics Covered

  1. Introduction
  2. Kaposi Sarcoma - Overview
  3. Kaposi Sarcoma - Therapeutics Development
  4. Kaposi Sarcoma - Therapeutics Assessment
  5. Kaposi Sarcoma - Companies Involved in Therapeutics Development
  6. Kaposi Sarcoma - Drug Profiles
  7. Kaposi Sarcoma - Dormant Projects
  8. Kaposi Sarcoma - Discontinued Products
  9. Kaposi Sarcoma - Product Development Milestones
  10. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/cjtbn4/pipeline_review?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Oncology Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Oncology Drugs